Equipped with high-precision cell and hydrogel dispensing capabilities combined with programmable shear-flow perfusion systems, the platform emulates physiological flow environments across diverse tissue interfaces. During model fabrication, real-time image recognition and data logging enable continuous quality monitoring, ensuring full transparency and traceability throughout the experimental workflow.

In practical applications, ProMEPS has demonstrated success in rapidly constructing and functionally assessing blood-brain barrier models, dynamically quantifying barrier integrity via transepithelial electrical resistance (TEER) monitoring. Furthermore, the system supports integration with multiple sensors for multidimensional evaluations—including metabolite detection and cell viability analysis—thereby providing multimodal data to elucidate drug mechanism of action.

Spanning from laboratory research to industrial-scale implementation, ProMEPS is increasingly adopted by global drug development organizations as a key enabling technology in organoid and microphysiological systems, owing to its high reliability, flexibility, and scalability.